Development of genetic markers in the non-structural protein 2 region of a US type 1 porcine reproductive and respiratory syndrome virus: Implications for future recombinant marker vaccine development

Journal of General Virology

Volumn 89, Issue 12, 2008, Pages 3086-3096

  Fang, Ying ^a   Christopher Hennings, Jane ^a   Brown, Elizabeth ^a   Liu, Haixia ^a   Chen, Zhenhai ^a   Lawson, Steven R ^a   Breen, Rachael ^a   Clement, Travis ^a   Gao, Xiaofei ^a   Bao, Jingjing ^a   Knudsen, David ^a   Daly, Russell ^a   Nelson, Eric ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GREEN FLUORESCENT PROTEIN; NONSTRUCTURAL PROTEIN 2; VIRUS VACCINE; CYSTEINE PROTEINASE; NSP2 PROTEINASE; PEPTIDE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTERIVIRUS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; INFECTION CONTROL; MARKER GENE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SWINE DISEASE; UNITED STATES; VIREMIA; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS RECOMBINANT; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CLASSIFICATION; EVALUATION; GENE DELETION; GENETIC MARKER; GENETICS; HAMSTER; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; SWINE; VIROLOGY;

ANIMALIA; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE;

AMINO ACID SEQUENCE; ANIMALS; CRICETINAE; CYSTEINE ENDOPEPTIDASES; EPITOPES; GENE DELETION; GENETIC MARKERS; GREEN FLUORESCENT PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDES; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 58149378585     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.2008/003426-0     Document Type: Article

References (61)

1. Allende, R., Lewis, T. L., Lu, Z., Rock D. L., Kutish, G. F., Ali, A., Doster, A. R. & Osorio, F. A. (1999). North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions. J Gen Virol 80, 307-315.
2. Babiuk L. A. (1999). Broadening the approaches to developing more effective vaccines. Vaccine 17, 1587-1595.
3. Babiuk L. A., Lewis, J., Suradhat, S., Baca-Estrada, M., Foldvari, M. Babiuk S. (1999). Polynucleotide vaccines: potential for inducing immunity in animals. J Biotechnol 73, 131-140.
4. Babiuk L. A., Babiuk, S. L. & Baca-Estrada, M. E. (2002). Novel vaccine strategies. Adv Virus Res 58, 29-80.
5. Barrett, T., Parlda, S., Mohapatra, M., Walsh, P., Das, S. & Baron, M. D. (2003). Development of new generation rinderpest vaccines. Dev Biol (Basel) 114, 89-97.
6. Bautista, E. M., Goyal, S. M., Soon, I. J., Joo, H. S. & Collins, J. E. (1996). Structural polypeptides of the American (VR-2332) strain of porcine reproductive and respiratory syndrome virus. Arch Virol 141, 1357-1365.
7. Bosch, J. C., Kaashoek M. J., Kroese, A. H. & Van Oirschot, J. T. (1996). An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet Microbiol 52, 223-234.
8. Castillo-Olivares, J., Wieringa, R., Bakonyi, T., de Vries, A. A., Davis-Poynter, N. J. & Rottler, P. J. (2003). Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain. J Virol 77, 8470-8480.
9. de Lima, M., PattnaiK A. K., Flores, E. F. & Osorio, F. A. (2006). Mapping of B-cell linear epitopes on Nsp2 and structural proteins of a North Ameriean strain of porcine reproductive and respiratory syndrome virus. Virology 353, 410-421.
10. de Lima, M., Kwon., B., Ansarl, I. H., Pattnaik A. K., Flores, E. F. & Osorio, F. A. (2008). Development of a porcine reproductive and respiratory syndrome virus differentiable (DIVA) strain through deletion of specific immunodominant epitopes. Vaccine 26, 3594-3600.
11. den Boon, J. A, Faaberg, K. S., Meulenberg, J. J. M., Wassenaar, A. L. M., Plagemann, P. G. W., Gorbelenya, A. E. & Snijder, E. J. (1995). Processing and evolution of the N-terminal region of the arterivirus replicase ORF1a protein: identification of two papainlike cysteine proteases. J Virol 69, 4500-4505.
12. Dong, X. N. & Chen, Y. H. (2007). Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 25, 205-230.
13. Fang, Y., Kim, D. Y., Ropp, S., Steen, P., Christopher-Hennings, J., Nelson, E. A. & Rowland, R. R. R. (2004). Heterogeneity in Nsp2 of European-like porcine reproductive and respiratory syndrome viruses isolated in the United States. Virus Res 100, 229-235.
14. Fang, Y., Rowland, R. R. R., Roof, M., Lunney, J. K., Christopher-Hennings, J. & Nelson, E. A. (2006). A full-length cDNA infectious clone of North American type 1 porcine reproductive and respiratory syndrome virus: expression of green fluorescent protein in the Nsp2 region. J Virol 80, 11447-11455.
15. Fang, Y., Schneider, P., Zhang, W. P., Faaberg, K, Nelson, E. A. & Rowland, R. R. R. (2007). Diversity and evolution of a newly emerged North American Type 1 porcine arterivirus. Arch Virol 152, 1009-1017.
16. Ferrin, N. H., Fang, Y., Johnson, C. R., Murtaugh, M. P., Poison, D. D., Torremorell, M., Gramer, M. L. & Nelson, E. A. (2004). Validation of a blocking ELISA for the detection of antibodies against porcine reproductive and respiratory syndrome virus. Clin Diagn Lab Immunol 11, 503-514.
17. Floegel-Niesmann, G. (2003). Marker vaccines and companion diagnostic tests for classical swine fever. Dev Biol (Basel) 114, 185-191.
18. Frias-Staheii, N., Glannakopoulos, N. V., Kikkert M, Taylor, S. L., Bridgen, A., Paragas, J., Richt, J. A., Rowland, R. R. R., Schmaljohn, C. S. & other authors (2007). Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2, 404-416.
19. Gao, Z. O., Guo, X. & Yang, H. C. (2004). Genomic characterization of two Chinese isolates of Porcine respiratory and reproductive syndrome virus. Arch Virol 149, 1341-1351.
20. Han, J., Liu, G., Wang, Y. & Faaberg, K. S. (2007). Identification of nonessential regions of the nsp2 replicase protein of porcine reproductive and respiratory syndrome virus strain VR-2332 for replication in cell culture. J Virol 81, 9878-9890.
21. Hayashi, N., Weischof, M., Zewe, M., Braunagel, M., Dübel, S., Breitling, F. & Little, M. (1994). Simultaneous mutagenesis of antibody CDR regions by overlap extension and PCR. Biotechniques 17, 310-315.
22. Hopp, T. P. & Woods, K. R. (1981). Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 78, 3824-3828.
23. Kaashoek, M. J., Moerman, A., Madic, J., Rijsewijk, F. A., Quak, J., Gielkens, A. L. & van Oirschot, J. T. (1994). A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12, 439-444.
24. Kim, D. Y., Calvert J. G., Chang, K. O., Horlen, K., Kerrigan, M. & Rowland, R. R. R. (2007). Expression and stability of foreign tags inserted into nsp2 of porcine reproductive and respiratory syndrome virus (PRRSV). Virus Res 128, 106-114.
25. Labarque, G., Van Reath, K., Nauwynck H., Drexler, C., Van Gucht S. & Pensaert, M. (2004). Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine 22, 4183-4190.
26. Lawson, S., Fang, Y., Rowland, R. R. R., Christopher-Hennings, J. & Nelson, E. A. (2005). Experimental infection of pigs with European-like (Type 1) PRRSV isolates of US origin. In The 86th Annual Meeting of the Conference of Research Workers in Animal Diseases, abstract no. 99, 4-6 December 2005, St Louis, Missouri, USA.
27. Mardassi, H., Massive, B. & Dea, S. (1996). Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology 221, 98-112.
28. Martelli, P., Cordioli, P., Alborali, L. G., Gozio, S., De Angelis, E., Ferrari, L., Lombardi, G. & Borghetti, P. (2007). Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain. Vaccine 25, 3400-3408.
29. Mebatsion, T., Koolen, M. J. M., de Vaan, L. T. C., de Haas, N., Braber, M., Romer-Oberdorfer, A., van den Eizen, P. & van der Marel, P. (2002). Newcastle disease virus marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J Virol 76, 10138-10146.
30. Meng, X. J., Paul, P. S., Morozov, I. & Halbur, P. G. (1996). A nested set of six or seven subgenomic mRNAs is formed in cells infected with different isolates of porcine reproductive and respiratory syndrome virus. J Gen Virol 77, 1265-1270.
31. Mengeling, W. L., Lager, K. M. & Vorwald, A. C. (1999). Safety and efficacy of vaccination of pregnant gilts against porcine reproductive and respiratory syndrome. Am J Vet Res 60, 796-801.
32. Meulenberg, J. J. & Petersen-den Besten, A. (1996). Identification and characterization of a sixth structural protein of Lelystad virus: the glycoprotein GP2 encoded by ORF2 is incorporated in virus particles. Virology 225, 44-51.
33. Meuienberg, J. J., Hulst M. M., de Meijer, E. J., Moonen, P. L., den Besten, A., de Kluyver, E. P., Wensvoort, G. & Moormann, R. J. (1993). Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV. Virology 192, 62-72.
34. Meulenberg, J. J., Petersen-den Besten, A., de Kluyver, A., Moormann, E. P., Schaaper, R. J. M. & Wensvoort, G. (1995). Characterization ofproteins encoded by ORFs 2 to 7 of Lelystad virus. Virology 206, 155-163.
35. Moormann, R. J., de Rover, T., Briaire, J., Peelers, B. P., Gielkens, A. L. & van Oirschot, J. T. (1990). Inactivation of the thymidine kinase gene of a g1 deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J Gen Virol 71, 1591-1595.
36. Mounir, S., Mardassi, H. & Dea, S. (1995). Identification and characterization of the porcine reproductive and respiratory virus ORFs 7, 5 and 4 products. Adv Exp Med Biol 380, 317-320.
37. Nelsen, C. J., Murtaugh, M. P. & Faaberg, K. S. (1999). Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. J Virol 73, 270-280.
38. Nelson, E. A., Christopher-Hennings, J., Wensvooft G., Collins, J. E. & Benfield, D. A. (1993). Differentiation of United States and European isolates of porcine reproductive and respiratory syndrome (PRRS) virus using monoclonal antibodies. J Clin Microbiol 31, 3184-3189.
39. Neumann, E. J., Kliebenstein, J. B., Johnson, C. D., Mabry, J. W., Bush, E. J., Seitzinger, A. H., Green, A. L. & Zimmerman, J. J. (2005). Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J Am Vet Med Assoc 227, 385-392.
40. Oleksiewicz, M. B., Botner, A., Tolt, P., Normann, P. & Storgaard, T. (2001). Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes. J Virol 75, 3277-3290.
41. Osorio, F. A., Zuckermann, F., Wills, R., Meier, W., Christian, S., Galeota, J. & Doster, A. (1998). PRRSV: comparison of commercial vaccines in their ability to induce protection against current PRRSV strains of high virulence. Allen D Leman Swine Conf 25, 176-182.
42. Ran, Z. G., Chen, X. Y., Guo, X., Ge, X. N., Yoon, K. J. & Yang, H. (2008). Recovery of viable porcine reproductive and respiratory syndrome virus from an infectious done containing a partial deletion within the Nsp2-encoding region. Arch Virol 153, 899-907.
43. Ropp, S. L., Mahlum Wees, C. E., Fang, Y., Nelson, E. A., Rossow, K. D., Bien, M., Arndt, B., Preszler, S., Steen, P. & other authors (2004). Characterization of emerging European-like PRRSV isolates in the United States. J Virol 78, 3684-3703.
44. Shen, S., Kwang, J., Liu, W. & Liu, D. X. (2000). Determination of the complete nudeotide sequence of a vaccine strain of porcine reproductive and respiratory syndrome virus and identification of the Nsp2 gene with a unique insertion. Arch Virol 145, 871-883.
45. Snijder, E. J. & Meulenberg, J. J. (1998). The molecular biology of arteriviruses. J Gen Virol 79, 961-979.
46. Snijder, E. J., Wassenaar, A. L. M. & Spaan, W. J. M. (1994). Proteolytic processing of the replicase ORF1a protein of equine arteritis virus. J Virol 68, 5755-5764.
47. Snijder, E. J., Wassenaar, A. L. M., Spaan, W. J. M. Gorbalenya, A. E. (1995). The arterivirus Nsp2 protease. An unusual cysteine protease with primary structure similarities to both papain-like and chymotrypsin-like proteases. J Biol Chem 270, 16671-16676.
48. Sun, T., Lu, P. & Wang, K. (2004). Localization of infection-related epitopes on the non-structural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes. J Virol Methods 119, 79-86.
49. Tian, K., Yu, X., Zhao, T., Feng, Y., Cao, Z., Wang, C., Hu, Y., Chen, X., Hu, D. & other authors (2007). Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. PLoS ONE 2, e526.
50. rns or E2 of CSFV. Vaccine 20, 1544-1556.
51. van Oirschot, J. T. (1999). Diva vaccines that reduce virus transmission. J Biotechnol 73, 195-205.
52. van Oirschot J. T. (2001). Present and future of veterinary viral vaccinology: a review. Vet Q 23, 100-108.
53. van Oirschot, J. T., Kaashoek M. J., Rijsewijk, F. A. & Stegeman, J. A. (1996). The use of marker vaccines in eradication of herpesviruses. J Biotechnol 44, 75-81.
54. Walsh, E. P., Baron, M. D., Rennie, L. F., Anderson, J. & Barrett T. (2000a). Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein. J Gen Virol 81, 709-718.
55. Walsh, E. P., Baron, M. D., Rennie, L. F., Monaghan, P., Anderson, J. & Barrett T. (2000b). Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope. J Virol 74, 10165-10175.
56. Wasilk A., Callahan, J., Christopher-Hennings, J., Gay, B. T., Fang, Y., Darnmen, M., Reos, M. E., Torremorell, M., Poison D. & other authors (2004). Detection of U.S. and Lelystad/European-like porcine reproductive and respiratory syndrome virus and relative quantitation in boar semen and serum by real-time PCR. J Clin Microbiol 42, 4453-4461.
57. Wassenaar, A. L., Spaan, W. J., Gorbalenya, A. E. & Snijder, E. J. (1997). Alternative proteolytic processing of the artenvirus replicase ORF1a polyprotein: evidence that Nsp2 acts as a cofactor forthe Nsp4 serine protease. J Virol 71, 9313-9322.
58. rns deletion mutants: trans-complementation and potential use as non transmissible, modified, live-attenuated marker vaccines. J Virol 74, 2973-2980.
59. Wu, W. H., Fang, Y., Farwell, R., Steffen-Bien, M., Rowland, R. R. R., Christopher-Hennings, J. & Nelson, E. A. (2001). A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF 2b. Virology 287, 183-191.
60. Wu, W. H., Fang, Y., Rowland, R. R. R., Lawson, S. R., Christopher-Hennings, J., Yoon, K. J. & Nelson, E. A. (2005). The 2b protein as a minor structural component of PRRSV. Virus Res 114, 177-181.
61. Yuan, S., Murtaugh, M. P., Schumann, F. A., Mickelson, D. & Faaberg, K. S. (2004). Characterization of heterodite subgenomic RNAs associated with PRRSV infection. Virus Res 105, 75-87.